ALLO
Common StockAllogene Therapeutics, Inc.
Reported Shares
22M
Position Mix
No options reported
Reported Value
$36.4M
Portfolio Weight
22.13%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$164.2M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
ALLO
Common StockAllogene Therapeutics, Inc.
Reported Shares
22M
Position Mix
No options reported
Reported Value
$36.4M
Portfolio Weight
22.13%
ARVN
Common StockARVINAS, INC.
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$26.2M
Portfolio Weight
15.98%
CELC
Common StockCelcuity Inc.
Reported Shares
295.7K
Position Mix
No options reported
Reported Value
$23.5M
Portfolio Weight
14.31%
AGMB
Depositary ReceiptAgomab Therapeutics NV
Reported Shares
2.2M
Position Mix
No options reported
Reported Value
$22.6M
Portfolio Weight
13.77%
PYXS
Common StockPyxis Oncology, Inc.
Reported Shares
7M
Position Mix
No options reported
Reported Value
$20.1M
Portfolio Weight
12.25%
WVE
Common StockWave Life Sciences, Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$7.1M
Portfolio Weight
4.32%
BHVN
Common StockBiohaven Ltd.
Reported Shares
505.6K
Position Mix
No options reported
Reported Value
$6.6M
Portfolio Weight
4.00%
CRBU
Common StockCaribou Biosciences, Inc.
Reported Shares
4.7M
Position Mix
No options reported
Reported Value
$5.8M
Portfolio Weight
3.54%
ORIC
Common StockOric Pharmaceuticals, Inc.
Reported Shares
372.9K
Position Mix
No options reported
Reported Value
$4.9M
Portfolio Weight
2.99%
CRDF
Common StockCardiff Oncology, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$3.0M
Portfolio Weight
1.82%
SPRO
Common StockSpero Therapeutics, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$2.9M
Portfolio Weight
1.77%
ZNTL
Common StockZentalis Pharmaceuticals, Inc.
Reported Shares
953.8K
Position Mix
No options reported
Reported Value
$2.6M
Portfolio Weight
1.57%
ZURA
Common StockZura Bio Ltd
Reported Shares
538.8K
Position Mix
No options reported
Reported Value
$2.2M
Portfolio Weight
1.33%
NXTC
Common StockNextCure, Inc.
Reported Shares
44.4K
Position Mix
No options reported
Reported Value
$225.3K
Portfolio Weight
0.14%
BOLT
Common StockBolt Biotherapeutics, Inc.
Reported Shares
31.3K
Position Mix
No options reported
Reported Value
$112.1K
Portfolio Weight
0.07%
DNA
Common StockGinkgo Bioworks Holdings, Inc.
Reported Shares
2.9K
Position Mix
No options reported
Reported Value
$31.2K
Portfolio Weight
0.02%
SENS
Common StockSenseonics Holdings, Inc.
Reported Shares
2.2K
Position Mix
No options reported
Reported Value
$21.7K
Portfolio Weight
0.01%